Aragon Purchased For $650M+

Source: PharmaManufacturing.com

Jun 18, 2013

USA Today

Aragon Pharmaceuticals has been bought by Johnson & Johnson for at least $650 million. J&J hopes to boost its position in prostate drug development. Aragon is a privately held company focused on the development of drugs to treat hormonally-driven cancers. The deal made between Aragon and J&J allows for additional payments of up to $350 million if certain milestones are met. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments